Talacotuzumab Vedotin Biosimilar - Research Grade
Product Specifications
Background
Talacotuzumab-MMAE is an ADC consisting of an IL-3Rα-directed antibody and Monomethyl auristatin E (MMAE) used for the study of acute myeloid leukemia.
Product Name Alternative
MMAE
Host
CHO Cells
Reactivity
Human
Target
IL-3Ra / CD123
Applications
Functional Assays
Concentration
1mg/mL
Purity
>90% by SDS-PAGE
Shipping Conditions
Room Temp
Storage Conditions
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Fragment
IgG1
Formulation
25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
Applications Notes
Reconstitute with sterile, distilled water to a final concentration of 1 mg/ml. Gently shake to solubilize completely. Do not vortex.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC040181-500 1x 500 µL
CD59 (heavy chain of Protectin) (BRA-10G), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040630-500 1x 500 µL
Mucin 1 / EMA / Episialin / CD227 (VU-2G7), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400460-500 1x 500 µL
CD44 Standard (156-3C11), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680525-100 1x 100 µL
CD63 (MX-49.129.5), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470270-100 1x 100 µL
Fibronectin (HFN7.1), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details